Investors
Value proposition
to-BBB aims to create strong value for patients and investors by:
- developing broadly applicable platform technologies targeting the biggest problem of the fast growing, multibillion CNS market;
- pursuing an open collaborative research strategy to optimize partnering income which will provide for early self-sustainability;
- combining established compounds and technologies in a novel way providing for a long patent life as much as for a predictable and straightforward drug development plan;
- employing an efficient team of scientific, business, medical and support professionals all sharing the entrepreneurial spirit of wanting to bring products to patients.
More information can be found in our Corporate fact sheet, or contact Investor Relations.
Investors
Besides management and informal investors, to-BBB's investors include:
 |
 |
 |
 |
| Aescap Venture | Antea Participaties |
Industrial Bank of Taiwan Management Corp. |
Jonghoud International |
Grants & Loans
Among others, to-BBB was awarded the following grants and loans:
.png) |
.gif) |
 |
 |
|
Agentschap NL
|
|
Rabobank
Credit Facility
|
.png)
.png)
.png){kind=small}
.png){kind=small}
.png){kind=small}